CVS vs DGX
CVS Health (CVS) and Quest Diagnostics (DGX) compared side by side. CVS Health (CVS) is larger, with a market cap of $119.5B versus $26.7B for Quest Diagnostics, about 4.5 times the size. On trailing earnings, DGX is cheaper at 24.1x versus 24.6x for CVS.
Head to head
| Metric | CVS | DGX |
|---|---|---|
| Market cap | $119.5B | $26.7B |
| P/E (TTM) | 24.6x | 24.1x |
| Forward P/E | 11.0x | 20.2x |
| Revenue (TTM) | $412.6B | $11.8B |
| Revenue growth | 7.1% | 10.0% |
| Gross margin | 13.6% | 33.2% |
| Operating margin | 3.9% | 15.6% |
| Free cash flow | $11.8B | $1.3B |
| Dividend yield | 2.85% | 1.42% |
| 1-year return | +18.8% | +34.2% |
| 5-year return (annual) | +4.8% | +12.7% |
| Max drawdown | -83% | -49% |
| FI Handbook grade | C- | C+ |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
CVS vs DGX FAQ
Which is bigger, CVS or DGX?
CVS Health (CVS) is larger, with a market cap of $119.5B versus $26.7B for Quest Diagnostics, about 4.5 times the size.
Is CVS or DGX cheaper?
On trailing earnings, DGX is cheaper at 24.1x versus 24.6x for CVS. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, CVS or DGX?
DGX returned +34.2% over the past year including dividends, versus +18.8% for CVS, through October 23, 2026.
Which pays a higher dividend, CVS or DGX?
CVS yields 2.85% versus 1.42% for DGX.
Full pages: CVS Health · Quest Diagnostics